EMEA-000463-PIP02-10

Invented name	Glivec
Active substance	imatinib mesilate
Therapeutic area	Cardiovascular diseases
Decision number	P/85/2011
PIP number	EMEA-000463-PIP02-10
Pharmaceutical form(s)	Film-coated tablet Capsule, hard Age-appropriate oral solid dosage form
Condition(s) / indication(s)	Treatment of pulmonary arterial hypertension
Route(s) of administration	Oral use
Contact for public enquiries	Novartis Europharm Limited paediatric.enquiries@novartis.com Switzerland Phone: +41 61 324 1111 Fax: +41 61 324 8001
Decision type	P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s)

Add your rating

★ ★ ★ ★ ★